| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |